Management of lupus nephritis
Joint Authors
Source
Saudi Journal of Kidney Diseases and Transplantation
Issue
Vol. 11, Issue 3 (30 Jun. 2000), pp.381-395, 15 p.
Publisher
Saudi Center for Organ Transplantation
Publication Date
2000-06-30
Country of Publication
Saudi Arabia
No. of Pages
15
Main Subjects
Topics
Abstract EN
Renal disease is common in systemic lupus erythematosus (SLE) and significantly influences patient prognosis.
Immunosuppressive therapy has markedly improved outcome, however, it increases the risk of infection and cancer induction.
Although several therapeutic regimens have proved to be effective in controlling lupus nephritis (LN), optimal therapy is still a matter of discussion.
The following review summarizes our current knowledge in treating LN and discusses new aspects in pathogenesis.
Hopefully, continuing progress in uncovering details about the pathogenesis of SLE might lead to more diseasespecific approaches to treat the underlying immunological disorder.
American Psychological Association (APA)
Merkel, F.& Gross, O.& Weber, M.. 2000. Management of lupus nephritis. Saudi Journal of Kidney Diseases and Transplantation،Vol. 11, no. 3, pp.381-395.
https://search.emarefa.net/detail/BIM-62671
Modern Language Association (MLA)
Merkel, F.…[et al.]. Management of lupus nephritis. Saudi Journal of Kidney Diseases and Transplantation Vol. 11, no. 3 (Dec. 2000), pp.381-395.
https://search.emarefa.net/detail/BIM-62671
American Medical Association (AMA)
Merkel, F.& Gross, O.& Weber, M.. Management of lupus nephritis. Saudi Journal of Kidney Diseases and Transplantation. 2000. Vol. 11, no. 3, pp.381-395.
https://search.emarefa.net/detail/BIM-62671
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 390-395
Record ID
BIM-62671